Sundance Diagnostics
Grand Junction · Founded 2012
About Sundance Diagnostics
Sundance Diagnostics is working to develop the world's first genetic safety tests to predict a patient’s risk of antidepressant-induced suicidal thinking or behavior. There is a strong need to make pharmaceutical drugs safer for patients’especially when those drugs have serious side effects and are being sold to millions of people. Sundance is using the most advanced genetic technologies to develop its safety tests to predict a patient’s risk. The goal is to save lives, improve treatment, increase patient confidence in treatment, and reduce the cost of treatment. Founded in 2012, Sundance Diagnostics is based in Grand Junction, Colorado.
Company Facts
- Founded: 2012
- Legal name: SUNDANCE DIAGNOSTICS, INC.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $6.5K
- Funding stage: Seed
- Last round: Seed (May 2015)
- Website: sundancedx.com
- Phone: (303) 862-2770
Social Profiles
Canonical: https://fsome.com/organization/sundance-diagnostics-8353562 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.